1-20 of 32
Krina Patel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses

Clinical Trials & Observations
Sikander Ailawadhi, Bertrand Arnulf, Krina Patel, Michele Cavo, Ajay K. Nooka, Salomon Manier, Natalie Callander, Luciano J. Costa, Ravi Vij, Nizar J. Bahlis, Philippe Moreau, Scott Solomon, Ingerid Weum Abrahamsen, Rachid Baz, Annemiek Broijl, Christine Chen, Sundar Jagannath, Noopur Raje, Christof Scheid, Michel Delforge, Reuben Benjamin, Thomas Pabst, Shinsuke Iida, Jesús Berdeja, Sergio Giralt, Anna Truppel-Hartmann, Yanping Chen, Xiaobo Zhong, Fan Wu, Julia Piasecki, Laurie Eliason, Devender Dhanda, Jasper Felten, Andrea Caia, Mark Cook, Mihaela Popa McKiver, Paula Rodríguez-Otero
Journal: Blood
Blood (2024) 144 (23): 2389–2401.
https://doi.org/10.1182/blood.2024024582
Published: 2024
Includes: Supplemental data
Journal Articles

KarMMa-2 Cohort 2a: Efficacy and Safety of Idecabtagene Vicleucel in Clinical High-Risk Multiple Myeloma Patients with Early Relapse after Frontline Autologous Stem Cell Transplantation

Saad Usmani, Krina Patel, Parameswaran Hari, Jesus Berdeja, Melissa Alsina, Ravi Vij, Noopur Raje, Xavier Leleu, Madhav Dhodapkar, Ran Reshef, Anna Truppel-Hartmann, Debashree Basudhar, Ethan Thompson, Xirong Zheng, Revathi Ananthakrishnan, Chiara Greggio, Linda Favre-Kontula, Lars Sternas, Jesús San-Miguel
Journal: Blood
Blood (2022) 140 (Supplement 1): 875–877.
https://doi.org/10.1182/blood-2022-162469
Published: 2022
Journal Articles

Clinical Factors Associated to VTE in Multiple Myeloma Patients Treated with Daratumumab

Naveen G Subramanian, Fleur M. Aung, Krina Patel, Hans C. Lee, Shida Jin, Elliana Young, Cristhiam Mauricio Rojas Hernandez
Journal: Blood
Blood (2022) 140 (Supplement 1): 5177–5179.
https://doi.org/10.1182/blood-2022-160480
Published: 2022
Journal Articles

Idecabtagene Vicleucel (Ide-cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Who Have Received a Prior BCMA-Targeted Therapy: Real World, Multi-Institutional Experience

Christopher J. Ferreri, Michelle A.T. Hildebrandt, Hamza Hashmi, Leyla O. Shune, Joseph P. McGuirk, Douglas W. Sborov, Charlotte B Wagner, M. Hakan Kocoglu, Shebli Atrash, Peter M. Voorhees, Jack Khouri, Danai Dima, Aimaz Afrough, Aishwarya Sannareddy, Gary Simmons, James Davis, Nilesh Kalariya, Lauren C. Peres, Melissa Alsina, Frederick L. Locke, Surbhi Sidana, Doris K. Hansen, Krina Patel, Omar Alexis Castaneda Puglianini
Journal: Blood
Blood (2022) 140 (Supplement 1): 1856–1858.
https://doi.org/10.1182/blood-2022-164884
Published: 2022
Journal Articles

KarMMa-2 Cohort 2c: Efficacy and Safety of Idecabtagene Vicleucel in Patients with Clinical High-Risk Multiple Myeloma Due to Inadequate Response to Frontline Autologous Stem Cell Transplantation

Madhav Dhodapkar, Melissa Alsina, Jesus Berdeja, Krina Patel, Ravi Vij, Xavier Leleu, Anna Truppel-Hartmann, Debashree Basudhar, Ethan Thompson, Xirong Zheng, Revathi Ananthakrishnan, Linda Favre-Kontula, Chiara Greggio, Lars Sternas, David Siegel
Journal: Blood
Blood (2022) 140 (Supplement 1): 7441–7443.
https://doi.org/10.1182/blood-2022-162615
Published: 2022
Journal Articles

Initial Results of a Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in Newly Diagnosed and Previously Treated AL Amyloidosis

Hans C. Lee, Gregory P. Kaufman, Lei Feng, Astrid Murga, Ralph J. Johnson, Donna M. Weber, Sheeba K Thomas, Qaiser Bashir, Muzaffar H Qazilbash, Swaminathan P. Iyer, Krina Patel, Melody R. Becnel, Elisabet E. Manasanch, Robert Z. Orlowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 4428–4430.
https://doi.org/10.1182/blood-2022-167555
Published: 2022
Journal Articles

Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: The U.S. Myeloma CAR T Consortium Real World Experience

Jack Khouri, Hong Li, Doris K. Hansen, Surbhi Sidana, Leyla O. Shune, Shaun DeJarnette, Faiz Anwer, Douglas W Sborov, Charlotte B Wagner, M. Hakan Kocoglu, Shebli Atrash, Peter M. Voorhees, Jason Valent, Lauren C. Peres, Vanna Hovanky, Gary Simmons, Danai Dima, Nilesh Kalariya, Aimaz Afrough, Gurbakhash Kaur, Aishwarya Sannareddy, Christopher J. Ferreri, James Davis, Joseph P. McGuirk, Frederick L. Locke, Rachid C. Baz, Betty K. Hamilton, Melissa Alsina, Craig S. Sauter, Hamza Hashmi, Krina Patel
Journal: Blood
Blood (2022) 140 (Supplement 1): 10427–10429.
https://doi.org/10.1182/blood-2022-163464
Published: 2022
Journal Articles

Impact of Presence and Amount of Clonal Plasma Cells in Autografts Affect Outcomes in High-Risk Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplant

Oren Pasvolsky, Denái R Milton, Mikael Rauf, Sassine Ghanem, Adeel Masood, Ali H Mohamedi, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Paul Lin, Jeremy L. Ramdial, Yago Nieto, Guilin Tang, Hans C. Lee, Krina Patel, Partow Kebriaei, Sheeba K Thomas, Donna M. Weber, Robert Z. Orlowski, Katy Rezvani, Elizabeth J Shpall, Richard E Champlin, Pei Lin, Muzaffar H Qazilbash
Journal: Blood
Blood (2022) 140 (Supplement 1): 284–286.
https://doi.org/10.1182/blood-2022-157960
Published: 2022
Journal Articles

Factors Associated with Refractoriness or Early Progression after Idecabtagene Vicleucel (Ide-cel) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): U.S. Myeloma CAR T Consortium Real World Experience

Hamza Hashmi, Doris K. Hansen, Lauren C. Peres, Omar Alexis Castaneda Puglianini, Ciara L. Freeman, Gabriel De Avila, Surbhi Sidana, Leyla O. Shune, Douglas W. Sborov, James Davis, Charlotte B. Wagner, M. Hakan Kocoglu, Shebli Atrash, Peter M. Voorhees, Gary Simmons, Christopher J. Ferreri, Nilesh Kalariya, Aishwarya Sannareddy, Danai Dima, Jack Khouri, Joseph P. McGuirk, Frederick L. Locke, Rachid C. Baz, Krina Patel, Melissa Alsina
Journal: Blood
Blood (2022) 140 (Supplement 1): 4642–4645.
https://doi.org/10.1182/blood-2022-164828
Published: 2022
Journal Articles

Single Cell Profiling of BCMA Naïve Vs Refractory Relapsed Myeloma Patients Reveals Unique Transcriptomic Profiles in Tumor and Microenvironment

Minghao Dang, Li Qin, Wei Tan, Liping Dong, Hans C. Lee, Krina Patel, Luz Yurany Moreno Rueda, Pei Lin, Hima Bansal, David Berrios, Sheeba K Thomas, Donna M. Weber, David E. Symer, Linghua Wang, Elisabet E. Manasanch, Robert Z. Orlowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 7122–7124.
https://doi.org/10.1182/blood-2022-165540
Published: 2022
Journal Articles

Idecabtagene Vicleucel Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma with Renal Insufficiency: Real World Experience

Surbhi Sidana, Lauren C. Peres, Hamza Hashmi, Hitomi Hosoya, Christopher J. Ferreri, Shebli Atrash, Jack Khouri, Peter M. Voorhees, Danai Dima, Gary Simmons, Nilesh Kalariya, Vanna Hovanky, Sushma Bharadwaj, Sally Arai, David B. Miklos, Charlotte B Wagner, James Davis, Douglas W. Sborov, Taiga Nishihori, Melissa Alsina, Frederick L. Locke, Rebecca Gonzalez, M. Hakan Kocoglu, Aishwarya Sannareddy, Aimaz Afrough, Joseph P. McGuirk, Leyla O. Shune, Krina Patel, Doris K. Hansen
Journal: Blood
Blood (2022) 140 (Supplement 1): 10377–10379.
https://doi.org/10.1182/blood-2022-166058
Published: 2022
Journal Articles

Safety, Tolerability, PK/PD and Preliminary Efficacy of NKTR-255, a Novel IL-15 Receptor Agonist, in Patients with Relapsed/Refractory Hematologic Malignancies

Krina Patel, Nina Shah, Alan Tan, Andrew J Cowan, Cameron J. Turtle, Craig C Hofmeister, Taewoong Choi, Hayder Saeed, Julio C. Chavez, Matthew J. Pianko, Mitul Gandhi, Sohail A. Chaudhry, Zachary Lee, Neha Dixit, Christie Fanton, Xiaoli Wang, Heng Xu, Mario Q. Marcondes, Mary A. Tagliaferri, Jonathan Zalevsky, Miguel-Angel Perales
Journal: Blood
Blood (2022) 140 (Supplement 1): 10357–10359.
https://doi.org/10.1182/blood-2022-162539
Published: 2022
Journal Articles

Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4:14): The MD Anderson Cancer Center Experience

Oren Pasvolsky, Denái R Milton, Adeel Masood, Sophiya S Shehzad, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Jeremy L. Ramdial, Yago Nieto, Hans C. Lee, Krina Patel, Partow Kebriaei, Sheeba K Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J Shpall, Richard E Champlin, Muzaffar H Qazilbash
Journal: Blood
Blood (2022) 140 (Supplement 1): 10589–10591.
https://doi.org/10.1182/blood-2022-162465
Published: 2022
Journal Articles

Racial and Ethnic Differences in Clinical Outcomes Among Multiple Myeloma Patients Treated with CAR T Therapy

Lauren C. Peres, Laura B. Oswald, Christen Dillard, Gabriel De Avila, Taiga Nishihori, Brandon J. Blue, Ciara L. Freeman, Frederick L. Locke, Melissa Alsina, Omar Alexis Castaneda Puglianini, Leyla O. Shune, Douglas W. Sborov, Charlotte B Wagner, Danai Dima, Hamza Hashmi, James Davis, M. Hakan Kocoglu, Shebli Atrash, Gary Simmons, Nilesh Kalariya, Christopher J. Ferreri, Aishwarya Sannareddy, Aimaz Afrough, Peter M. Voorhees, Jack Khouri, Joseph P. McGuirk, Surbhi Sidana, Doris K. Hansen, Krina Patel
Journal: Blood
Blood (2022) 140 (Supplement 1): 623–625.
https://doi.org/10.1182/blood-2022-158478
Published: 2022
Journal Articles

Carfilzomib-Based Combination Regimens Are Highly Effective Frontline Therapies for Multiple Myeloma and Waldenström's Macroglobulinemia

Maria Chaudhry, MBBS, Raphael Steiner, MD, Catherine M. Claussen, MS, Krina Patel, MD, Hans C. Lee, MD, Donna M. Weber, MD, Sheeba K. Thomas, MD, Chun Feng, Mark Kramer, Behrang Amini, MD, Robert Z. Orlowski, MD PhD, Lei Feng, MS, Elisabet E. Manasanch, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1880.
https://doi.org/10.1182/blood.V130.Suppl_1.1880.1880
Published: 2017
Journal Articles

Outcome of Autologous Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Multiple Myeloma

Lauren Westfall Veltri, MD, Denái R. Milton, Nina Shah, MD, Krina Patel, MD, Yago Nieto, MD PhD, Partow Kebriaei, MD, Uday R. Popat, MD, Simrit Parmar, MD, Betul Oran, MD, Stefan O. Ciurea, MD, Chitra Hosing, MD, Hans Lee, MD, Elisabet E. Manasanch, MD, Robert Z. Orlowski, PhD, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD
Journal: Blood
Blood (2016) 128 (22): 4626.
https://doi.org/10.1182/blood.V128.22.4626.4626
Published: 2016
Journal Articles

Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation

Muzaffar H. Qazilbash, MD, Edward A Stadtmauer, MD, Veera Baladandayuthapani, PhD, Heather Lin, M.S., Beryl M. Tross, Medhavi Honhar, MBBS, Soung-Chul Cha, PhD, Kunhwa Kim, MD, Sheetal S Rao, PhD, Michael Popescu, MD, Nina Shah, MD, Qaiser Bashir, MD, Krina Patel, MD, Elizabeth J. Shpall, MD, Donna M. Weber, MD, Sheeba K. Thomas, MD, Jatin J. Shah, MD, Robert Z. Orlowski, PhD, MD, Naseem DS Kerr, MPH, Alfred L. Garfall, MD, Adam D. Cohen, MD, Karen Dengel, BSN, RN, Carl H June, MD, Richard E. Champlin, MD, Larry Kwak, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4548.
https://doi.org/10.1182/blood.V128.22.4548.4548
Published: 2016
Journal Articles

Impact of New Anti-Leukemia Agents on Transplant Outcomes in Adults with Acute Lymphoblastic Leukemia (ALL) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) in Second Complete Remission

Sara Lozano Cerrada, MD, David Marin, MD, Gabriela Rondon, MD, Celina Ledesma, BS, Uday R. Popat, MD, Amanda L. Olson, MD, Amin M. Alousi, MD, Betul Oran, MD, Sairah Ahmed, MD, Stefan O. Ciurea, MD, Krina Patel, MD, Elizabeth J. Shpall, MD, Chitra Hosing, MD, Muzaffar H. Qazilbash, MD, Nina Shah, MD, Katayoun Rezvani, MD, PhD, Elias Jabbour, MD, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Partow Kebriaei, MD
Journal: Blood
Blood (2016) 128 (22): 4676.
https://doi.org/10.1182/blood.V128.22.4676.4676
Published: 2016
Journal Articles

Additional Consolidation after Attaining Second Complete Remission Results in Superior Outcomes after Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia

Sara Lozano Cerrada, MD, David Marin, MD, Gabriela Rondon, MD, Celina Ledesma, BS, Uday R. Popat, MD, Amanda Olson, MD, Amin Alousi, MD, Betul Oran, MD, Sairah Ahmed, MD, Stefan O. Ciurea, MD, Krina Patel, MD, Elizabeth J. Shpall, MD, Chitra Hosing, MD, Muzaffar H. Qazilbash, MD, Nina Shah, MD, Katy Rezvani, MD PhD, Elias Jabbour, MD, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Partow Kebriaei, MD
Journal: Blood
Blood (2016) 128 (22): 4680.
https://doi.org/10.1182/blood.V128.22.4680.4680
Published: 2016
Journal Articles

Gene Expression Profiling Predicts Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients in a Standard of Care Setting

Catherine M Claussen, MS, Hans Lee, MD, Jatin J. Shah, MD, Tiffany Richards, ANP, Nina Shah, MD, Krina Patel, MD, Qaiser Bashir, MD, Simrit Parmar, MD, Sheeba Thomas, MD, Yago Nieto, MD PhD, Muzaffar H. Qazilbash, MD, Richard Eric Davis, MD, Sattva S. Neelapu, MD, Donna M. Weber, MD, Robert Z. Orlowski, PhD, MD, Lei Feng, MS, Elisabet E. Manasanch, MD
Journal: Blood
Blood (2016) 128 (22): 5628.
https://doi.org/10.1182/blood.V128.22.5628.5628
Published: 2016